Melafolone
Melafolone is a potent dual COX-2/EGFR inhibitor with IC50s of 13.2 μM (COX-2) and 17.4 μM (EGFR) . Melafolone enhances the effect of anti-PD-1 through vascular normalization and PD-L1 downregulation via the PI3K/Akt pathway in Lewis lung carcinoma (LLC) and CMT167 models. Melafolone can be used for lung cancer research[1].
Product Specifications
CAS Number
129724-42-1
UNSPSC
12352005
Target
Akt; COX; EGFR; PD-1/PD-L1; PI3K
Related Pathways
Immunology/Inflammation; JAK/STAT Signaling; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=C(C1=C(C(OC(C(C)CC)=O)=C(C(OC)=C1O)O)OC)/C=C/C2=CC=CC=C2
Molecular Formula
C22H24O7
Molecular Weight
400.42
References & Citations
[1]Tang H, et al. Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer. J Pharmacol Exp Ther. 2019 Mar;368 (3) :401-413.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
COX-2; EGFR/ErbB1/HER1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
